{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:00:22Z","timestamp":1782910822899,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jogc.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T17:07:04Z","timestamp":1588007224000},"page":"1532-1542.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-3822","authenticated-orcid":false,"given":"Ian","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2020.04.006_bib0001","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.jogc.2020.04.006_bib0002","unstructured":"World Health Organization. Induced abortion. 2012:1\u20133. https:\/\/www.who.int\/reproductivehealth\/publications\/unsafe_abortion\/rhr_12_02\/en\/."},{"key":"10.1016\/j.jogc.2020.04.006_bib0003","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(14)60696-6","article-title":"Global, regional, and national levels and causes of maternal mortality during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Kassebaum","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0004","unstructured":"Gynuity Health Projects. Mifepristone approvals. Available at: http:\/\/gynuity.org\/downloads\/biblio_ref_lst__mife.pdf. Accessed January 21, 2015."},{"key":"10.1016\/j.jogc.2020.04.006_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0006","first-page":"1339","article-title":"Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden","volume":"81","author":"Jones","year":"2001","journal-title":"Phys Ther"},{"key":"10.1016\/j.jogc.2020.04.006_bib0007","series-title":"Safe abortion: technical and policy guidance for health systems","year":"2012"},{"key":"10.1016\/j.jogc.2020.04.006_bib0008","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0010-7824(96)00044-3","article-title":"Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion","volume":"53","author":"Bugalho","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misoprostol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1363\/3816412","article-title":"Use of medicines changing the face of abortion","volume":"38","author":"Winikoff","year":"2012","journal-title":"Int Perspect Sex Reprod Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0012","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1471-0528.1990.tb02516.x","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial","volume":"97","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.jogc.2020.04.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002855.pub3","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2020.04.006_bib0014","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-4755-9-34","article-title":"Latin American women's experiences with medical abortion in settings where abortion is legally restricted","volume":"9","author":"Zamberlin","year":"2012","journal-title":"Reprod Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jogc.2020.04.006_bib0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ijgo.12356","article-title":"Mifepristone-misoprostol for menstrual regulation in public sector facilities in Bangladesh","volume":"140","author":"Alam","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0017","doi-asserted-by":"crossref","unstructured":"Johnson BR Jr, Maksutova E, Boobekova A, et al. Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas. 2018;97:160\u20136.","DOI":"10.1016\/j.contraception.2017.11.002"},{"key":"10.1016\/j.jogc.2020.04.006_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191174","article-title":"Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: a non-inferiority study in Nepal","volume":"13","author":"Rocca","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2020.04.006_bib0019","doi-asserted-by":"crossref","first-page":"269","DOI":"10.33314\/jnhrc.v16i3.1378","article-title":"Safety, efficacy and acceptability of early first trimester abortion using oral mifepristone and sublingual misoprostol","volume":"16","author":"Shrestha","year":"2018","journal-title":"J Nepal Health Res Counc"},{"key":"10.1016\/j.jogc.2020.04.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179600","article-title":"Is self-assessment of medical abortion using a low-sensitivity pregnancy test combined with a checklist and phone text messages feasible in South African primary healthcare settings? A randomized trial","volume":"12","author":"Constant","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2020.04.006_bib0021","first-page":"197","article-title":"Results of first trimester medical abortion care","author":"Solongos","year":"2017","journal-title":"Japan Soc Obstet Gynecol"},{"key":"10.1016\/j.jogc.2020.04.006_bib0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12978-017-0438-7","article-title":"Comparative satisfaction of receiving medical abortion service from nurses and auxiliary nurse-midwives or doctors in Nepal: results of a randomized trial","volume":"14","author":"Tamang","year":"2017","journal-title":"Reprod Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijgo.2015.11.009","article-title":"Efficacy of early induced medical abortion with mifepristone when beginning progestin-only contraception on the same day","volume":"133","author":"Douthwaite","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.contraception.2015.07.001","article-title":"Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study","volume":"92","author":"Blanchard","year":"2015","journal-title":"Contraception"},{"issue":"44 Suppl 1","key":"10.1016\/j.jogc.2020.04.006_bib0025","first-page":"56","article-title":"The introduction of first trimester medical abortion in Armenia","volume":"22","author":"Louie","year":"2015","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.jogc.2020.04.006_bib0026","first-page":"e537","article-title":"Home use of misoprostol for early medical abortion in a low resource setting: secondary analysis of a randomized controlled trial","volume":"3","author":"Iyengar","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2020.04.006_bib0027","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0968-8080(14)43795-9","article-title":"Increasing access to safe menstrual regulation services in Bangladesh by offering medical menstrual regulation","volume":"22","author":"Yasmin","year":"2015","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.jogc.2020.04.006_bib0028","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijgo.2015.08.025","article-title":"Progestin-based contraceptive on the same day as medical abortion","volume":"133","author":"Park","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0029","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.contraception.2013.11.005","article-title":"Provision of medical abortion using telemedicine in Brazil","volume":"89","author":"Gomperts","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3126\/kumj.v12i3.13715","article-title":"A randomized trial of hospital vs home self administration of vaginal misoprostol for medical abortion","volume":"12","author":"Shrestha","year":"2014","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"10.1016\/j.jogc.2020.04.006_bib0031","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijgo.2014.04.012","article-title":"Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City","volume":"127","author":"Pe\u00f1a","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0032","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/13625187.2014.933956","article-title":"Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan","volume":"19","author":"Louie","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jogc.2020.04.006_bib0033","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3126\/kumj.v11i3.12505","article-title":"Medical abortion versus manual vacuum aspiration in a Hilly District Hospital of Eastern Nepal: a comparative study","volume":"11","author":"Panta","year":"2013","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"10.1016\/j.jogc.2020.04.006_bib0034","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s13224-013-0407-1","article-title":"A prospective trial using mifepristone and vaginal misoprostol in termination of pregnancies up to 63 days of gestation","volume":"63","author":"Sonal","year":"2013","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.jogc.2020.04.006_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.contraception.2013.10.018","article-title":"A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days\u2019 LMP: a prospective comparative open-label trial","volume":"89","author":"Bracken","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0036","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0412.2011.01285.x","article-title":"Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine","volume":"91","author":"Gomperts","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2020.04.006_bib0037","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.contraception.2011.12.012","article-title":"A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion","volume":"86","author":"Chong","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0038","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijgo.2012.03.039","article-title":"Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam","volume":"118","author":"Blum","year":"2012","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0039","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4755-8-19","article-title":"Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in northwest Ethiopia","volume":"8","author":"Woldetsadik","year":"2011","journal-title":"Reprod Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)62229-5","article-title":"Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal","volume":"377","author":"Warriner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0041","first-page":"213","article-title":"Prospective study of medical abortion in Nepal Medical College Teaching Hospital (NMCTH). A one year experience","volume":"13","author":"Giri","year":"2011","journal-title":"Nepal Med Coll J"},{"key":"10.1016\/j.jogc.2020.04.006_bib0042","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial","volume":"117","author":"Von Hertzen","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2020.04.006_bib0043","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.contraception.2010.04.031","article-title":"Introducing medical abortion in Nepal with minimal technology","volume":"82","author":"Castleman","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2020.04.006_bib0044","first-page":"78","article-title":"Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial","volume":"35","author":"Chawdhary","year":"2009","journal-title":"J Obstet Gynecol Res"},{"key":"10.1016\/j.jogc.2020.04.006_bib0045","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-0528.2008.01787.x","article-title":"Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services","volume":"115","author":"Gomperts","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2020.04.006_bib0046","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2298\/VSP0606558S","article-title":"[Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro.]","volume":"63","author":"Stojni\u0107","year":"2006","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.jogc.2020.04.006_bib0047","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1479-828X.2005.00380.x","article-title":"Early medical abortion: a new regimen up to 49 days\u2019 gestation","volume":"45","author":"Ashima","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2020.04.006_bib0048","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4103\/0019-5359.16505","article-title":"Evaluation of the efficacy of mifepristone\/misoprostol and methotrexate for medical abortion","volume":"59","author":"Dahiya","year":"2005","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.jogc.2020.04.006_bib0049","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1471-0528.2003.02430.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy","volume":"110","author":"Von Hertzen","year":"2003","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.jogc.2020.04.006_bib0050","article-title":"Doctors or mid-level providers for abortion (Review)","author":"Barnard","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2020.04.006_bib0051","article-title":"Acceptability of home-assessment post medical abortion and medical abortion in a low-resource setting in Rajasthan, India. Secondary outcome analysis of a non-inferiority randomized controlled trial","volume":"10","author":"Mandira","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jogc.2020.04.006_bib0052","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-0528.2004.00153.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion","volume":"111","author":"Honkanen","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2020.04.006_bib0053","first-page":"1","article-title":"Improving access to safe abortion in a rural primary care setting in India: experience of a service delivery intervention","author":"Iyengar","year":"2016","journal-title":"Reprod Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0054","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijgo.2013.11.015","article-title":"Service users\u2019 attributes associated with the uptake of medical versus surgical abortion at public health facilities in Vietnam","volume":"125","author":"Ngo","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ijgo.12022","article-title":"Abortion choices among women in Cambodia after introduction of a socially marketed medicated abortion","volume":"136","author":"Sotheary","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13691058.2015.1078911","article-title":"Women's experiences with medication for menstrual regulation in Bangladesh","volume":"18","author":"Marlow","year":"2016","journal-title":"Cult Health Sex"},{"issue":"44 Suppl 1","key":"10.1016\/j.jogc.2020.04.006_bib0057","first-page":"104","article-title":"Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion","volume":"22","author":"Tamang","year":"2015","journal-title":"Reprod Health Matters"},{"issue":"44 Suppl 1","key":"10.1016\/j.jogc.2020.04.006_bib0058","first-page":"47","article-title":"Towards safe abortion access: an exploratory study of medical abortion in Cambodia","volume":"22","author":"Petitet","year":"2015","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.jogc.2020.04.006_bib0059","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.contraception.2006.03.013","article-title":"Providing medication abortion information to diverse communities: use patterns of a multilingual web site","volume":"74","author":"Foster","year":"2006","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2020.04.006_bib0060","first-page":"S33","article-title":"Medical abortion: understanding perspectives of rural and marginalized women from rural South India","volume":"118","author":"Sri","year":"2012","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2020.04.006_bib0061","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17441690802551340","article-title":"Understanding women's experiences with medical abortion: in-depth interviews with women in two Indian clinics","volume":"5","author":"Ganatra","year":"2010","journal-title":"Glob Public Health"},{"key":"10.1016\/j.jogc.2020.04.006_bib0062","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0968-8080(05)26199-2","article-title":"Women's perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: a qualitative study","volume":"13","author":"Lafaurie","year":"2005","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.jogc.2020.04.006_bib0063","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0968-8080(05)26195-5","article-title":"Medical abortion in rural Tamil Nadu, South India: a quiet transformation","volume":"13","author":"Ramchandar","year":"2005","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.jogc.2020.04.006_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120637","article-title":"Delivering medical abortion at scale: a study of the retail market for medical abortion in Madhya Pradesh, India","volume":"10","author":"Powell-Jackson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2020.04.006_bib0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12909-016-0532-5","article-title":"Medical students are afraid to include abortion in their future practices: in-depth interviews in Maharastra, India","volume":"16","author":"Sj\u00f6str\u00f6m","year":"2016","journal-title":"BMC Med Educ"},{"key":"10.1016\/j.jogc.2020.04.006_bib0066","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14656566.4.4.503","article-title":"Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia","volume":"4","author":"Murthy","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jogc.2020.04.006_bib0067","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2004.07.011","article-title":"The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion","volume":"71","author":"Creinin","year":"2005","journal-title":"Contraception"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121632030339X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121632030339X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:37:46Z","timestamp":1761665866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S170121632030339X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S170121632030339X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2020.04.006","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}